News Archive
Research Highlight: New Genetic Scoring Guide for B-ALL Using SALSA® digitalMLPA™ Probemix D007 Acute Lymphoblastic Leukemia
In a recent research article published in the British Journal of Cancer, Bedics et al. developed a new B-ALL classifier using SALSA digitalMLPA Probemix D007 Acute Lymphoblastic Leukemia.
Improved: SALSA MLPA Probemix ME029 FMR1-AFF2 - Changes to Content and Protocol
We are glad to inform you that we have released an improved version of SALSA® MLPA® Probemix ME029 FMR1-AFF2, accompanied by a new product-specific protocol.
New: SALSA MLPA Probemix ME053 BRCA1-BRCA2-RAD51C
We are glad to announce the launch of ME053 BRCA1-BRCA2-RAD51C.
2022 - A Year in Review
SALSA MC002 SMA Newborn Screen, SALSA digitalMLPA Probemix D001 Hereditary Cancer Panel 1 and SALSA MLPA Probemix P008 PMS2 were the products with the largest growth compare to 2021.
New Customs Regulations Outside EU
For non-EU customers who order directly from MRC Holland, we are required to add a surcharge of €0.01 on Sample DNAs (SDs) that are included as accessory items with selected MLPA assays.
P495-A1 CYP11A1-CYP11B1-CYP11B2 – New MLPA Probemix Launched
We are happy to announce the launch of our new SALSA MLPA Probemix P495-A1 CYP11A1-CYP11B1-CYP11B2.
Revolutionising the Analysis of Hematologic Malignancies: Multiple Myeloma and Acute Lymphoblastic Leukemia
We are pleased to announce the launch of two new SALSA® digitalMLPA™ assays in the field of hematologic malignancies: D006 Multiple Myeloma and D007 Acute Lymphoblastic Leukemia.